Aballi John Insider Trades

Insider Trading History

Track insider trading activity for Aballi John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Exagen
Exagen XGN
President And CEO
Holding Value $3.81M 839,834 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$474k 150,000 shares
$3.16
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $795k 175,000 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 100,000 shares
$3.16
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.13M 689,834 shares
Last Trade
Mar 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.7k 2,535 shares
$3.43
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.12M 687,299 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$56.8k 15,698 shares
$3.62
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.19M 702,997 shares
Last Trade
Feb 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.3k 11,430 shares
$3.61
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.24M 714,427 shares
Last Trade
Oct 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$376k 31,787 shares
$11.82
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.39M 746,214 shares
Last Trade
Feb 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.8k 8,621 shares
$3.46
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.35M 737,593 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 75,000 shares
$3.58
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $3.13M 689,799 shares
Last Trade
Nov 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$68.3k 24,305 shares
$2.81
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $183k 40,401 shares
Last Trade
May 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$77.6k 40,401 shares
$1.92
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $2.73M 600,788 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 9,804 shares
$2.25
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $2.68M 590,984 shares
Last Trade
Feb 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$369k 175,000 shares
$2.11
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $1.89M 415,984 shares
Last Trade
Oct 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$59.2k 33,819 shares
$1.75
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $2.04M 449,803 shares
Last Trade
Aug 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.7k 9,803 shares
$2.52
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $2M 440,000 shares
Last Trade
Dec 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$241k 90,000 shares
$2.68
$4.54
Exagen
Exagen XGN
President And CEO
Holding Value $1.59M 350,000 shares
Last Trade
Oct 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$851k 350,000 shares
$2.43
$4.54

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up